CYTOMX THERAPEUTICS INC. |
USA |
Gesundheit |
US23284F1057 / A14158 |
6C1 (Frankfurt) / CTMX (NASDAQ) |
FRA:6C1, ETR:6C1, 6C1:GR, NASDAQ:CTMX |
- |
https://cytomx.com/ |
388.47 Mio. EUR |
127.24 Mio. EUR |
32.47 Mio. EUR |
0.362 EUR |
7.03 Mio. EUR |
68.89 Mio. EUR |
22.8% / 70.6% |
5.5 / 8 |
1.54 / 16.6 / - |
28.19% / - |
- |
- / - |
CYTOMX |
03.07.25 |
|